TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MENS

Jyong Biotech Ltd.

Healthcare · Biotechnology

2.00$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Jyong Biotech Ltd. (MENS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 36.3% of the shares are freely tradable; institutional investors hold 0.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 62.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 36.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 74Mio.

Largest Shareholders

Institutions

Institutions MENS
Name Stake (%) Shares Change (%) Date
BlackRock Inc 0.35 258,760 -0.8 03/31/2026
Geode Capital Management, LLC 0.09 64,232 -0.2 03/31/2026
UBS Group AG 0.05 37,363 -74.3 03/31/2026
China Universal Asset Mgmt Co.Ltd 0.02 12,100 -8.1 06/30/2026
HRT FINANCIAL LLC 0.02 11,767 +0.0 03/31/2026
Tower Research Capital LLC 0.02 11,703 +144.6 03/31/2026

Funds

Funds MENS
Name Stake (%) Shares Change (%) Date
iShares Biotechnology ETF 0.29 216,819 +0.8 08/31/2026
iShares Nasdaq US Biotech ETF USD Acc 0.08 57,167 +1.1 08/28/2026
Fidelity Nasdaq Composite Index 0.06 46,713 +10.8 07/31/2026
Fidelity Nasdaq Composite ETF 0.04 26,707 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?